Enrichment analysis revealed that the molecular mechanisms of BD treatment of UC are associated with IL-17, TNF-α, and Toll-like receptor signaling pathways, and that these signaling pathways all point to NF-κB-based inflammatory signaling pathways. The gene discussed is IL17A; the disease is Behcet disease.